Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Dr Reddys Laboratories , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Dr. Reddy's Laboratories Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price3095.0
Previous Share Price3120.75
Price Change -25.75
Change % -0.825%
Volume711.05 K
Five Day Avg Vol860.97 K
Fno StockYes, F&O list
Last Business Date01-Apr-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 173.00 5.92
Two Weeks 426.55 15.98
One Month 167.90 5.74
Three Months 215.60 7.49
Six Months 405.65 15.08
One Year 300.20 10.74

Highs / Lows

One Week3152.02811.0
Two Weeks3152.02495.05
One Month3231.952495.05
Three Months3364.952495.05
Six Months3364.952495.05
One Year3364.952351.2

Key Moving Average

5 Days 3015.013025.91
15 Days 2877.112957.73
20 Days 2937.262962.29
50 Days 3063.352992.02
100 Days 2974.572957.11
200 Days 2812.582865.48
Detailed MA Analysis of DRREDDY ...

Key Technical Indicators

MACD -11.06
RSI 60.73
RSI (Smooth) 56.36
ADX 20.89
Chaikin Money Flow 0.0277
Williams %R -8.68
PSAR 2553.59
Detailed Tech Analysis DRREDDY ...

Financial Data Highlights

Market Cap49374.46
Book Value/ Share896.872
Enterprise Value11365.38
Revenue TTM17044.80
Gross Profit TTM8343.00
Revenue /Share TTM1028.27
Consensus Target2587.45
Key Financial Highlights DRREDDY ...

Financial Ratios of DRREDDY

Div Yield0.680
Trailing PE30.60
Forward PE26.30
Key Financial Ratios of DRREDDY ...

Key Profit & Loss Data

Net Inc 1879.50 91.67 %
Ops Income2008.20 67.00 %
Revenue15385.10 8.46 %
Ops Expense13376.90 3.03 %
PBT2244.30 56.50 %
Gross Profit8343.00 9.34 %
Div Paid-332.00 0.090 %

Futures of DRREDDY

Closing Price3103.30
Premium/Discount 8.30
Price Change -32.20
Change % -1.03
Future OI2254.50 K
OI Change % 0.390
Future Contracts2854.00
Contracts Change -43.01
Lot Size250

Put / Call Options

Call Max Traded Strike Price3300.00
Call Max Traded SP Contracts149
Call Option Open Interest92.25 K
Call Option OI Chg % 13.89
Put Max Traded Strike Price3000.00
Put Max Traded SP Contracts145
Put Option Open Interest49.00 K
Put Option OI Chg % 35.17
Option Chain With Impled Vol & Greeks ...

Put Call Ratio - 30/04/2020

Put Open Interest49.00 K
Call Open Interest92.25 K
PCR Open Interest0.531
PCR OI ReadingBullish
Put Contracts Traded259.00
Call Contracts Traded489.00
PCR Volume0.530
PCR Vol ReadingBullish
Put Call Ratio DRREDDY ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR78.002.52
Week PR341.0011.02
Month PR78.002.52
5 Day Period159.455.51
10 Day Period201.337.23
5 Week Period448.0517.05
3 Months Period598.3022.68
Price Range /Volatility DRREDDY ...

Highlights & Chart Patterns of Dr. Reddy's Laboratories Ltd.

Stock has jumped by more than 10% in last two weeks from its lowest level of 2495.05 dt 19-Mar-20
Stock has jumped by more than 15% in last One Month from its lowest level of 2495.05 dt 19-Mar-20.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Bearish harami Candlestick pattern was formed by Dr. Reddy's Laboratories Ltd. on 01/04/2020 Prior to pattern formation this share was in uptrend.
Three outside up Candlestick pattern was formed by Dr. Reddy's Laboratories Ltd. on 31/03/2020 with rise in volume. Prior to pattern formation this share was in uptrend.
Bullish engulfing Candlestick pattern was formed by Dr. Reddy's Laboratories Ltd. on 30/03/2020 with rise in volume. Prior to pattern formation this share was in uptrend.
As Per ADX, stock is in mild trend with ADX of 20.8948 and is trending for 0 Days
More Chart Patterns Dr. Reddy's Laboratories Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Dr. Reddy's Laboratories Ltd.

Date Open High Low Close Volume
01-Apr-20 3119.95 3144.00 3066.00 3095.00 711 K
31-Mar-20 3050.00 3152.00 3032.05 3120.75 1002 K
30-Mar-20 2879.60 3050.00 2811.00 2994.25 1150 K
27-Mar-20 2952.80 3046.95 2846.10 2916.50 801 K
26-Mar-20 2975.20 3066.55 2879.25 2948.55 638 K
25-Mar-20 2827.25 2948.90 2795.70 2922.00 819 K
24-Mar-20 2850.00 2960.00 2801.10 2857.95 1068 K
23-Mar-20 2680.25 3047.00 2680.25 2768.40 963 K
20-Mar-20 2641.00 2949.00 2641.00 2897.25 1554 K
19-Mar-20 2608.00 2679.90 2495.05 2623.95 967 K
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. As of March 31, 2019, it had six late stage projects at various stages of development. The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company also offers diabetes nutrition drink under the Celevida brand name. It has collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.